A Portal for Glycated Albumin and its applications
Study Determines Specific Biomarker Roles for Glycated Albumin and HbA1c in Patients with Type 2 Diabetes on Hemodialysis
September 19, 2016
A recent report in the Journal of Diabetes and Its Complications investigated whether glycated albumin (GA) and HbA1c could “represent glycemic profiles in hemodialysis.” The study on patients with hemodialysis determined that “HbA1c correlates [with] the average glucose more than GA but underestimates it. [Therefore], a correction formula of HbA1c can be developed as an appreciable marker.” Also, even though average glucose is reflected less accurately with GA than with HbA1c, GA “could serve as an indicator for hyperglycemia/hypoglycemia excursion.” 97 patients with type 2 diabetes were continuously monitored in order to establish whether GA and HbA1c were suitable glycemic indicators.